Crescent Biopharma (CBIO) Cash from Investing Activities (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.71% |
| Dec 31, 2025 | -12,219.62% |
| Sep 30, 2025 | -318.57% |
| Jun 30, 2024 | 65.95% |
| Mar 31, 2024 | -828.71% |
| Dec 31, 2023 | 89.82% |
| Sep 30, 2023 | 25.30% |
| Jun 30, 2023 | -379.29% |
| Mar 31, 2023 | -219,600.00% |
| Dec 31, 2022 | 99.96% |
| Sep 30, 2022 | 93.97% |
| Jun 30, 2022 | -1.64% |
| Mar 31, 2022 | -1,555.95% |
| Dec 31, 2021 | 43.54% |
| Sep 30, 2021 | 15.05% |
| Jun 30, 2021 | -66.73% |
| Mar 31, 2021 | 91.98% |
| Dec 31, 2020 | -141.42% |
| Sep 30, 2020 | -147.74% |
| Jun 30, 2020 | 21.55% |
| Mar 31, 2020 | 34.16% |
| Dec 31, 2019 | 32.35% |
| Sep 30, 2019 | 75.57% |
| Jun 30, 2019 | -89.10% |
| Mar 31, 2019 | 30.64% |
| Dec 31, 2018 | -114.62% |
| Sep 30, 2018 | -4.42% |
| Jun 30, 2018 | -53.06% |
| Mar 31, 2018 | 51.48% |
| Dec 31, 2017 | -4.77% |
| Sep 30, 2017 | 80.09% |
| Jun 30, 2017 | -160.77% |
| Mar 31, 2017 | 85.64% |
| Dec 31, 2016 | -94.59% |
| Sep 30, 2016 | -880.79% |
| Jun 30, 2016 | -33.06% |
| Mar 31, 2016 | -435.17% |
| Dec 31, 2015 | 94.47% |
| Sep 30, 2015 | 71.47% |
| Jun 30, 2015 | -8,648.87% |
| Mar 31, 2015 | 84.27% |
| Dec 31, 2014 | 85.43% |
| Sep 30, 2014 | -24.67% |
| Jun 30, 2014 | -487.77% |
| Mar 31, 2014 | -11.99% |
| Dec 31, 2013 | 68.27% |
| Sep 30, 2013 | -65.49% |
| Jun 30, 2013 | -246.83% |